letrozole has been researched along with Sarcoma, Endometrial Stromal in 11 studies
Sarcoma, Endometrial Stromal: A highly malignant subset of neoplasms arising from the endometrial stroma. Tumors in this group infiltrate the stroma with a wide range of atypia cells and numerous mitoses. They are capable of widespread metastases (NEOPLASM METASTASIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Letrozole is a type 2 aromatase inhibitor that effectively reduces serum estrogen levels." | 6.46 | Treatment of recurrent endometrial stromal sarcoma with letrozole: a case report and literature review. ( Dunton, CJ; Sylvestre, VT, 2010) |
| "Low-grade endometrial stromal sarcoma is an indolent steroid responsive tumor." | 5.32 | Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. ( Amy, JJ; Bourgain, C; Breugelmans, M; De Sutter, P; Leunen, M, 2004) |
| "Letrozole was then given at a daily dose of 2." | 5.31 | Endometrial stromal sarcoma: objective response to letrozole. ( Aghajanian, C; Maluf, FC; Sabbatini, P; Schwartz, L; Xia, J, 2001) |
| "Letrozole is a type 2 aromatase inhibitor that effectively reduces serum estrogen levels." | 2.46 | Treatment of recurrent endometrial stromal sarcoma with letrozole: a case report and literature review. ( Dunton, CJ; Sylvestre, VT, 2010) |
| "Low-grade endometrial stromal sarcoma is a rare neoplastic growth in the uterine cavity, representing less than 1% of uterine tumors." | 1.62 | Complete remission of advanced low-grade endometrial stromal sarcoma after aromatase inhibitor therapy: a case report. ( Al Sharie, AH; Aleshawi, A; Alfaqih, M; Altal, OF; Halalsheh, OM; Shaban, S; Tashtush, N, 2021) |
| "Low-grade endometrial stromal sarcoma is an indolent steroid responsive tumor." | 1.32 | Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole. ( Amy, JJ; Bourgain, C; Breugelmans, M; De Sutter, P; Leunen, M, 2004) |
| "Letrozole was then given at a daily dose of 2." | 1.31 | Endometrial stromal sarcoma: objective response to letrozole. ( Aghajanian, C; Maluf, FC; Sabbatini, P; Schwartz, L; Xia, J, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J | 1 |
| Wang, J | 1 |
| Cao, D | 1 |
| Yang, J | 1 |
| Huang, H | 1 |
| Pan, L | 1 |
| Xiang, Y | 1 |
| Altal, OF | 1 |
| Al Sharie, AH | 1 |
| Halalsheh, OM | 1 |
| Tashtush, N | 1 |
| Shaban, S | 1 |
| Alfaqih, M | 1 |
| Aleshawi, A | 1 |
| Manuel, V | 1 |
| Dinato, FJ | 1 |
| Gutierrez, PS | 1 |
| Siqueira, SAC | 1 |
| Gaiotto, FA | 1 |
| Jatene, FB | 1 |
| Yang, KH | 1 |
| Shin, JA | 1 |
| Jung, JH | 1 |
| Jung, HW | 1 |
| Lee, HR | 1 |
| Chang, S | 1 |
| Park, JY | 1 |
| Yi, SY | 1 |
| Dahhan, T | 1 |
| Fons, G | 1 |
| Buist, MR | 1 |
| Ten Kate, FJ | 1 |
| van der Velden, J | 1 |
| Tzakas, E | 1 |
| Liu, S | 1 |
| Todd, RW | 1 |
| Redman, CW | 1 |
| Sylvestre, VT | 1 |
| Dunton, CJ | 1 |
| Leunen, M | 1 |
| Breugelmans, M | 1 |
| De Sutter, P | 1 |
| Bourgain, C | 1 |
| Amy, JJ | 1 |
| Reich, O | 1 |
| Regauer, S | 1 |
| Bréchot, JM | 1 |
| Kamboucher, M | 1 |
| Brauner, M | 1 |
| Destable, MD | 1 |
| Duperron, F | 1 |
| Morère, JF | 1 |
| Maluf, FC | 1 |
| Sabbatini, P | 1 |
| Schwartz, L | 1 |
| Xia, J | 1 |
| Aghajanian, C | 1 |
1 review available for letrozole and Sarcoma, Endometrial Stromal
| Article | Year |
|---|---|
Treatment of recurrent endometrial stromal sarcoma with letrozole: a case report and literature review.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Endometrial Neoplasms; Female; Humans; Letroz | 2010 |
10 other studies available for letrozole and Sarcoma, Endometrial Stromal
| Article | Year |
|---|---|
Low-grade endometrial stromal sarcoma with intracaval or intracardiac extension: a retrospective study of eight cases.
Topics: Adult; Endometrial Neoplasms; Female; Humans; Letrozole; Medroxyprogesterone; Retrospective Studies; | 2022 |
Complete remission of advanced low-grade endometrial stromal sarcoma after aromatase inhibitor therapy: a case report.
Topics: Aromatase Inhibitors; Endometrial Neoplasms; Female; Humans; Letrozole; Middle Aged; Neoplasm Recurr | 2021 |
Cardiac metastatic endometrial stromal sarcoma 17 years after hysterectomy.
Topics: Antineoplastic Agents; Cardiac Surgical Procedures; Chemotherapy, Adjuvant; Endometrial Neoplasms; F | 2017 |
A Case of Metastatic Low-Grade Endometrial Stromal Sarcoma Treated with Letrozole after Ovarian Ablation by Radiotherapy.
Topics: Ablation Techniques; Antineoplastic Agents; Chemotherapy, Adjuvant; Endometrial Neoplasms; Female; H | 2015 |
The efficacy of hormonal treatment for residual or recurrent low-grade endometrial stromal sarcoma. A retrospective study.
Topics: Adult; Aged, 80 and over; Aromatase Inhibitors; Combined Modality Therapy; Dose-Response Relationshi | 2009 |
Hormonal therapy with letrozole prior to surgical management of recurrent metastatic low-grade endometrial stromal sarcoma (LGESS).
Topics: Antineoplastic Agents; Endometrial Neoplasms; Female; Humans; Letrozole; Middle Aged; Neoplasm Metas | 2009 |
Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole.
Topics: Aged; Antineoplastic Agents; Aromatase Inhibitors; Female; Humans; Letrozole; Neoplasm Recurrence, L | 2004 |
Hormonal treatment with aromatase inhibitors for patients with endometrial stromal sarcoma.
Topics: Aged; Aromatase Inhibitors; Endometrial Neoplasms; Female; Humans; Letrozole; Nitriles; Sarcoma, End | 2005 |
[Pulmonary metastases from endometrial stromal sarcoma may benefit from hormone therapy].
Topics: Aromatase Inhibitors; Endometrial Neoplasms; Female; Humans; Letrozole; Lung Neoplasms; Middle Aged; | 2007 |
Endometrial stromal sarcoma: objective response to letrozole.
Topics: Abdominal Neoplasms; Antineoplastic Agents; Endometrial Neoplasms; Female; Humans; Letrozole; Liver | 2001 |